Issue 36 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

2

No.

36

September 03, 1976Sep 03, 1976

Free

DOWNLOAD THE PDF

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

Nine Cancer Act Changes Considered By NCAB Subcommittee

Recent Issues

Volume 52 | Issue 34 - September 18, 2026

Volume 52 | Issue 33 - September 11, 2026

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026